Entana, Roxan .
HRN: 25-05-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/02/2024
08/09/2024
IV
500mg
Q8
Colonic Mass; Gut Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes